Evidence map›Paper›PMID 35431786›Full record

ArticleFrontiers in neuroscience2022

Molecular-Scale Dynamics of Long Range Retrograde Brain-Derived Neurotrophic Factor Transport Shaped by Cellular Spatial Context.

Anke Vermehren-Schmaedick, Mark J Olah, Damien Ramunno-Johnson, Keith A Lidke, Michael S Cohen, Tania Q Vu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Anke Vermehren-SchmaedickDepartment of Biomedical Engineering, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, United States.
Mark J OlahDepartment of Physics and Astronomy, University of New Mexico, Albuquerque, NM, United States.
Damien Ramunno-JohnsonDepartment of Biomedical Engineering, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, United States.
Keith A LidkeDepartment of Physics and Astronomy, University of New Mexico, Albuquerque, NM, United States.
Michael S CohenDepartment of Chemical Physiology and Biochemistry, Oregon Health and Science University, Portland, OR, United States.
Tania Q VuDepartment of Biomedical Engineering, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, United States.
Oregon Health & Science University · USUniversity of New Mexico · US

Funding

Molecular Digital CytoImaging for Leukemia Drug ScreeningR01CA222095 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI MARTIN, JODY, VU, TOTHU Q · 2018 to 2022
$2.9M
Neuronal signal transduction in space and time using single quantum dotsR01NS071116 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI VU, TOTHU Q · 2011 to 2015
$1.7M
Single Molecule Imaging to Quantify FcεRI Signaling DynamicsR01GM100114 · NIGMS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI LIDKE, DIANE · 2012 to 2016
$1.4M
Validation of the use of quantum dot-labeled proteins as biomarkers in vivoR21NS073113 · NINDS · UNIVERSITY OF NEVADA RENO · PI VON BARTHELD, CHRISTOPHER S · 2010 to 2011
$367k
NCI NIH HHS R01 CA222095NIGMS NIH HHS R01 GM100114NINDS NIH HHS R01 NS071116NINDS NIH HHS R21 NS073113
6 · The paper itself

Abstract

Retrograde neurotrophin (NT) transport is a specialized form of signal transduction used to conduct information from axons to the cell bodies of central and peripheral nervous system neurons. It is activated upon NT-Trk receptor binding, NT-Trk internalization into signaling endosomes, and their motion along the axon toward the cell body. Brain-derived neurotrophic factor (BDNF) is an abundant NT that modulates key brain and spinal cord functions, and defects in BDNF trafficking are associated with neuronal death, neurodegenerative diseases and in nerve injury. Decades of study have yielded impressive progress in elucidating NT retrograde transport; however, much information remains unclear. For example, while it is known that NT function is dependent on tight control of NT-receptor intracellular trafficking, data describing the precise spatiotemporal molecular dynamics of their axonal to somatic transport are lacking. In past work, we showed the use of discrete, photo-bleaching-resistant quantum dot (QD)-BNDF probes to activate and track BDNF-TrkB receptor internalization; this revealed a rich diversity of molecular motions that intracellular BDNF signaling endosomes undergo within the soma of nodose ganglia sensory neurons. Here, we used combined techniques of discrete QD-BDNF tracking with compartmented microfluidic chambers to characterize retrograde BDNF-TrkB transport over long-ranging distances of primary dorsal root ganglion sensory neuronal axons. Our new findings show that axonal retrograde motion is comprised of heterogeneous mixtures of diffusive behaviors, pauses, and variations in net molecular-motor-dependent transport speeds. Notably, specific molecular dynamic features such as NT speed were dependent on spatial context that could be categorized in distance from distal axons and proximity to the soma and were not entirely dictated by active motor transport speed. The important implication is recognition that NT-receptor retrograde transport is comprised of molecular dynamics, which change over the course of long-range trafficking to shape overall transport and possibly signaling.

Indexed as

axon-dendriteBDNFDRGmolecular dynamicsquantum dotretrograde transportsingle particle trackingsubcellular architecture

Identifiers

PMID35431786
PMCPMC9008462
OpenAlexW4220871197

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.